Elixinol Wellness Ltd (ASX: EXL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Elixinol Wellness Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Elixinol Wellness Ltd (ASX: EXL)
Latest News
Share Fallers
Why these ASX cannabis shares just crashed to all-time lows
Share Fallers
Elixinol share price slumps 6% after sale of Japanese cannabis arm
⏸️ Best ASX Shares
The only ASX cannabis share I'd consider buying
Share Fallers
Cannabis company Elixinol Global sinks lower on Q3 update
Share Fallers
Why Botanix, Elixinol Global, Pro Medicus, & Tinybeans shares tumbled lower
Share Fallers
Why cannabis company Elixinol Global crashed 10% lower today
⏸️ Shares to Watch
What is the best ASX cannabis share to buy for 2020?
Share Fallers
What's next for these 4 beaten-down ASX cannabis stocks?
Share Gainers
Why this beaten-down ASX cannabis stock is turning around
Growth Shares
3 beaten down ASX shares to watch in September
Share Fallers
2 falling ASX cannabis stocks to watch closely
Share Gainers
This ASX cannabis share just surged 16% higher after announcing a deal with Costco
EXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Elixinol Wellness Ltd
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.
EXL Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
27 Mar 2024 | $0.01 | $0.00 | 0.00% | 15,682,043 | $0.01 | $0.01 | $0.01 |
26 Mar 2024 | $0.01 | $0.00 | 0.00% | 410,861 | $0.01 | $0.01 | $0.01 |
25 Mar 2024 | $0.01 | $0.00 | 0.00% | 23,181,745 | $0.01 | $0.01 | $0.01 |
22 Mar 2024 | $0.01 | $0.00 | 0.00% | 7,761,660 | $0.01 | $0.01 | $0.01 |
21 Mar 2024 | $0.01 | $0.00 | 0.00% | 527,009 | $0.01 | $0.01 | $0.01 |
20 Mar 2024 | $0.01 | $0.00 | 0.00% | 1,697,652 | $0.01 | $0.01 | $0.01 |
19 Mar 2024 | $0.01 | $0.00 | 0.00% | 183,352 | $0.01 | $0.01 | $0.01 |
18 Mar 2024 | $0.01 | $0.00 | 0.00% | 39,497 | $0.01 | $0.01 | $0.01 |
15 Mar 2024 | $0.01 | $0.00 | 0.00% | 73,328 | $0.01 | $0.01 | $0.01 |
14 Mar 2024 | $0.01 | $0.00 | 0.00% | 198,290 | $0.01 | $0.01 | $0.01 |
13 Mar 2024 | $0.01 | $0.00 | 0.00% | 345,061 | $0.01 | $0.01 | $0.01 |
12 Mar 2024 | $0.01 | $0.00 | 0.00% | 181,359 | $0.01 | $0.01 | $0.01 |
11 Mar 2024 | $0.01 | $0.00 | 0.00% | 671,684 | $0.01 | $0.01 | $0.01 |
08 Mar 2024 | $0.01 | $0.00 | 0.00% | 2,327,051 | $0.01 | $0.01 | $0.01 |
07 Mar 2024 | $0.01 | $0.00 | 0.00% | 1,321,270 | $0.01 | $0.01 | $0.01 |
06 Mar 2024 | $0.01 | $0.00 | 0.00% | 16,181 | $0.01 | $0.01 | $0.01 |
05 Mar 2024 | $0.01 | $0.00 | 0.00% | 269,152 | $0.01 | $0.01 | $0.01 |
04 Mar 2024 | $0.01 | $0.00 | 0.00% | 25,000 | $0.01 | $0.01 | $0.01 |
01 Mar 2024 | $0.01 | $0.00 | 0.00% | 340,168 | $0.01 | $0.01 | $0.01 |
29 Feb 2024 | $0.01 | $0.00 | 0.00% | 294,865 | $0.01 | $0.01 | $0.01 |
28 Feb 2024 | $0.01 | $0.00 | 0.00% | 1,504,657 | $0.01 | $0.01 | $0.01 |
27 Feb 2024 | $0.01 | $0.00 | 0.00% | 6,058,632 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
06 Feb 2024 | Ron Dufficy | Expiry | 548,077 | $5,480 |
As advised by the company. Lapsing of Performance Share rights,31,71,994 Rights
|
23 Nov 2023 | Ron Dufficy | Exercise | 902,778 | $12,638 |
Conversion of securities. 37,20,071 Rights
|
23 Nov 2023 | Ron Dufficy | Issued | 902,778 | $12,638 |
Conversion of securities.
|
23 Nov 2023 | Ron Dufficy | Buy | 902,778 | $12,638 |
Issue of options.
|
23 Nov 2023 | David (Dave) Fenlon | Exercise | 625,000 | $8,750 |
Conversion of securities. 17,15,753 Rights
|
23 Nov 2023 | David (Dave) Fenlon | Issued | 625,000 | $8,750 |
Conversion of securities.
|
23 Nov 2023 | David (Dave) Fenlon | Issued | 625,000 | $8,750 |
Issue of options.
|
21 Sep 2023 | Pauline Gately | Sell | 1,796,428 | $10,778 |
On-market trade.
|
12 Sep 2023 | Pauline Gately | Sell | 43,859 | $350 |
On-market trade.
|
11 Sep 2023 | Pauline Gately | Sell | 803,976 | $6,431 |
On-market trade.
|
08 Sep 2023 | Pauline Gately | Sell | 705,318 | $5,642 |
On-market trade.
|
31 Aug 2023 | Ron Dufficy | Exercise | 902,778 | $9,027 |
Conversion of securities. 5,922,849 Rights
|
31 Aug 2023 | Ron Dufficy | Issued | 902,778 | $9,027 |
Issue of options.
|
31 Aug 2023 | Ron Dufficy | Issued | 902,778 | $9,027 |
Conversion of securities.
|
31 Aug 2023 | David (Dave) Fenlon | Issued | 625,000 | $6,250 |
Issue of options.
|
31 Aug 2023 | David (Dave) Fenlon | Issued | 625,000 | $6,250 |
Conversion of securities.
|
31 Aug 2023 | David (Dave) Fenlon | Exercise | 625,000 | $6,250 |
Conversion of securities. 23,40,753 Rights
|
31 Aug 2023 | Helen Wiseman | Issued | 763,889 | $7,638 |
Conversion of securities.
|
31 Aug 2023 | Helen Wiseman | Issued | 763,889 | $7,638 |
Issue of options.
|
31 Aug 2023 | Helen Wiseman | Exercise | 763,889 | $7,638 |
Conversion of securities. 33,35,091 Rights
|
07 Jun 2023 | Ron Dufficy | Issued | 555,556 | $7,777 |
Participation in share purchase plan.
|
07 Jun 2023 | Helen Wiseman | Issued | 555,556 | $7,777 |
Participation in share purchase plan.
|
31 May 2023 | Ron Dufficy | Exercise | 3,478,785 | $52,181 |
Conversion of securities. 68,25,627 Rights
|
31 May 2023 | Ron Dufficy | Issued | 4,778,785 | $105,554 |
Issue of securities. 1,03,04,412 Rights
|
31 May 2023 | Ron Dufficy | Issued | 3,611,112 | $65,000 |
Employee Share Ownership Plan/Directors Salary Sacrifice. 55,25,627 Rights
|
31 May 2023 | Ron Dufficy | Buy | 3,478,785 | $52,181 |
Conversion of securities.
|
31 May 2023 | David (Dave) Fenlon | Issued | 2,500,000 | $45,000 |
Director remuneration. 29,65,753 Rights
|
31 May 2023 | Helen Wiseman | Issued | 3,055,556 | $55,000 |
Director remuneration. 40,98,980 Rights
|
26 May 2023 | Helen Wiseman | Issued | 555,556 | $10,000 |
Participation in share purchase plan.
|
26 May 2023 | Helen Wiseman | Issued | 555,556 | $10,000 |
Participation in share purchase plan.
|
26 May 2023 | Ron Dufficy | Issued | 555,556 | $10,000 |
Participation in share purchase plan.
|
06 Apr 2023 | Paul Benhaim | Expiry | 652,566 | $14,356 |
As advised by the company. lapse of performance rights
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David (Dave) Fenlon | Non-Executive DirectorNon-Executive Chairman | Mar 2022 |
Mr Fenlon has over 30 years of experience in the FMCG and consumer sectors. He is currently CEO of The Platform Alliance Group, Non-Executive Chair for Nutritional Growth Solutions (ASX: NGS) and Non-Executive Director of Quest for Life Foundation. He was previously Group CEO and MD of BWX Limited (ASX: BWX), and prior to that, was MD for Australia and New Zealand at Blackmores (ASX: BKL). David has worked with retail brands both in Australia and offshore, with a strong focus on strategic planning and business transformation. David's experience also includes holding positions in Tesco throughout Europe and Safeway in the UK and he was a member of the Board of Directors for the Special Olympics from May 2017 until June 2019. He is member of Risk Committee.
|
Mr Ron Dufficy | Chief Executive OfficerManaging Director | Apr 2023 |
Mr Dufficy is a senior finance executive having held various financial leadership roles with ASX-listed companies such as CSR Ltd and Aristocrat Leisure Ltd. Ron has experience in regulated markets including being based in the USA for 9 years, most recently as Chief Financial Officer for Aristocrat's largest and most profitable division, responsible for developing and implementing strategies to improve profit margins, grow market share and creating a global shared services organisation.
|
Ms Pauline Therese Gately | Non-Executive Director | Aug 2023 |
--
|
Ms Sarah Prince | Joint Company Secretary | Apr 2023 |
-
|
Ms Josephine Lorenz | Chief Financial OfficerJoint Company Secretary | May 2023 |
-
|
Josephine Lorenz | Chief Financial OfficerJoint Company Secretary |
-
|
|
Ron Dufficy | Global Chief Executive Officer |
-
|
|
Josephine Lorenz | Global Chief Financial Officer |
-
|
|
Sarah Prince | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Raw With Life Pty Ltd (Benhaim Trading A/C) | 29,209,217 | 9.24% |
Citicorp Nominees Pty Limited | 16,300,377 | 5.15% |
D & G Health Llc | 5,119,229 | 1.62% |
BNP Paribas Noms Pty Ltd (Drp) | 4,411,662 | 1.39% |
BNP Paribas Nominees Pty Ltd Acf Clearstream | 4,294,462 | 1.36% |
Mrs Kelly Danielle Vagg | 3,537,770 | 1.12% |
Mr Eric Chi Keung Wong | 2,310,226 | 0.73% |
Mr Michael Ernest Granata (The Granata Family A/C) | 2,200,000 | 0.70% |
Merrill Lynch (Australia) Nominees Pty Limited | 2,017,205 | 0.64% |
Mr Jia Hong Zhang | 1,858,472 | 0.59% |
Panther Trading Pty Ltd (Panther A/C) | 1,576,471 | 0.50% |
Mr Jyotindra Subedi | 1,500,283 | 0.47% |
Mr Gabriel Georges Alkan | 1,467,982 | 0.46% |
HSBC Custody Nominees (Australia) Limited | 1,371,933 | 0.43% |
Ms Xiao Lan Wang | 1,339,568 | 0.42% |
Eighteen Holdings Pty Ltd | 1,300,000 | 0.41% |
Mr Raymond Windward Dyne | 1,300,000 | 0.41% |
Mr Kieran John O'Brien | 1,271,500 | 0.40% |
Kaneden Enterprises Pty Ltd (Roseburgh Family Super A/C) | 1,200,000 | 0.38% |
Ms Siu Ling Wu & Mr Chung Yin Liu | 1,194,135 | 0.38% |